1. Cell Cycle/DNA Damage Neuronal Signaling Apoptosis
  2. CDK Cholinesterase (ChE) Apoptosis
  3. ZLMT-12

ZLMT-12 (compound 35) 是他克宁衍生物,是一种有效的 CDK2/9 抑制剂,抑制 CDK9CDK2IC50 值分别为 0.002 和 0.011 μM。ZLMT-12 对 AChE (IC50=19.023 μM) 和 BuChE (IC50=2.768 μM) 有弱抑制作用。ZLMT-12 具有低毒和抗增殖活性。ZLMT-12 诱导细胞凋亡 (apoptosis),阻滞细胞周期在 S 期和 G2/M 期。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

ZLMT-12 Chemical Structure

ZLMT-12 Chemical Structure

CAS No. : 2841473-39-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

ZLMT-12 (compound 35), tacrine derivatives, is a potent, orally active CDK2/9 inhibitor with IC50 values of 0.002 and 0.011 μM for CDK9 and CDK2, respectively. ZLMT-12 has a weak inhibitory effect on AChE (IC50=19.023 μM) and BChE (IC50=2.768 μM). ZLMT-12 has low toxicity and antiproliferative activity. ZLMT-12 induces apoptosis and arrests the cell cycle in the S phase and G2/M phase[1].

IC50 & Target[1]

CDK9

0.002 μM (IC50)

CDK2

0.011 μM (IC50)

BChE

2.768 μM (IC50)

AChE

19.023 μM (IC50)

体外研究
(In Vitro)

ZLMT-12 (compound 35; 500 nM; 72 h) has antiproliferative activity in cancer cells[1].
ZLMT-12 (500 nM; 72 h) induces apoptosis and arrests the cell cycle in the S phase and G2/M phase[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: HCT116, SW480, A549, and MCF-7 cells
Concentration: 500 nM
Incubation Time: 72 hours
Result: Inhibited cell proliferative with GI50 values of 0.029, 0.328, 0.051, and 0.109 μM for HCT116, SW480, A549, and MCF-7 cells, respectively.

Apoptosis Analysis[1]

Cell Line: HCT116 cells
Concentration: 10 and 20 nM
Incubation Time: 48 hours
Result: Increased apoptotic cells rate from 9.22% in the control to 23.77% at 10 nM and increased apoptotic cells rate to 46.2% at 20 nM.

Cell Cycle Analysis[1]

Cell Line: HCT116 cells
Concentration: 10 and 20 nM
Incubation Time: 48 hours
Result: Increased the percentage of the S phase from 31.43% to 42.75% (10 nM) and 49.38% (20 nM) respectively, and the percentage of the G2/M phase from 6.39% to 10.60% (10 nM) and 13.11% (20 nM), respectively.
体内研究
(In Vivo)

ZLMT-12 (compound 35; 10 mg/kg; p.o.; daily, for 21 d) has antitumor efficacy and inhibits tumor growth, without causing liver harm in the HCT116 xenograft model[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male BALB/cA-nu mice with HCT116 xenografts (18-25 g, 6-8 weeks of age)[1]
Dosage: 10 mg/kg
Administration: Oral administration; daily, for 21 days
Result: Inhibited tumor growth with GI (tumor volume growth inhibition)=47.66% and TGI (tumor weight growth inhibition)=62.39%.
Exhibited no significant changes in behavior or body weight in mice.
Had no obvious liver injury.
Animal Model: Male Sprague-Dawley rats (240±20 g)[1]
Dosage: 2 mg/kg (i.v.) and 20 mg/kg (p.o.) (Pharmacokinetic Analysis)
Administration: Intravenous injection and oral administration; once
Result: 1.19
Parameter 2 mg/kg (i.v.) 20 mg/kg (p.o.)
T1/2 (h) 0.461 1.77
Tmax (h) 0.083/td> 1.00
Cmax (ng/mL) 206 67.8
AUCo-t (h*ng/mL) 110 302
AUCo-∞ (h*ng/mL) 115 316
CL (L/h/kg) 18.7
Vss(L/Kg) 12.6
F (%) 27.47
分子量

479.02

Formula

C26H31ClN6O

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
ZLMT-12
目录号:
HY-151436
需求量: